Skip to main content

Table 11 Change in HbA1c values (with HbA1c denoted in mmol/mol) after acarbose titration

From: The effect of oral diabetes medications on glycated haemoglobin (HbA1c) in Asians in primary care: a retrospective cohort real-world data study

Acarbose dose after titration

0

50

100

150

200

300

 

-3(-6, -1)#m=49

-4(-7, -3)#m=221

-7(-8, -4)#m=211

 

-7(-11, -1)#m=37

2(0, 4)#m=52

 

-3(-8, 0)#m=34

   

4(2, 6)#m=149

3(1, 6)#m=40

 

-2(-6, 0)#m=72

-2(-4, 0)#m=94

 

4(2, 6)#m=122

 

0(-1, 2)#m=65

  

-2(-3, 0)#m=144

4(2, 7)#m=67

 

3(2, 6)#m=48

  

-1(-3, 1)#m=75

7(4, 10)#m=82

  

7(3, 9)#m=49

3(2, 6)#m=92

 
  1. Change in HbA1c values after acarbose initiation, titration, or discontinuation. The values above the diagonal represent the instances where the medication has been initiated or up-titrated, while the values below the diagonal represent instances where the medication has been down-titrated or discontinued. The values refer to the mean difference in HbA1c (MD) and 95% confidence intervals. MD below 0 indicate a lowering in HbA1c while those above 0 indicate an increase in HbA1c. #m refers to the number of HbA1c pairs for that dose titration